Bellevue Group AG - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 140 filers reported holding CLOVIS ONCOLOGY INC in Q1 2016. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q1 2020$453,000
-40.4%
71,200
-2.3%
0.01%
-25.0%
Q4 2019$760,000
-3.1%
72,900
+322.6%
0.01%
-82.1%
Q2 2018$784,000
-16.3%
17,250
-2.8%
0.07%
-28.0%
Q1 2018$937,000
-23.4%
17,750
-1.4%
0.09%
-27.3%
Q4 2017$1,224,000
-19.7%
18,000
-2.7%
0.13%
-19.5%
Q3 2017$1,524,000
-12.0%
18,5000.0%0.16%
-22.4%
Q2 2017$1,732,000
+47.0%
18,5000.0%0.20%
+30.6%
Q1 2017$1,178,000
+32.7%
18,500
-7.5%
0.16%
-13.7%
Q4 2016$888,000
-42.7%
20,000
-53.5%
0.18%
-35.0%
Q3 2016$1,550,000
+53.8%
43,000
-18.1%
0.28%
+53.0%
Q1 2016$1,008,00052,5000.18%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q1 2016
NameSharesValueWeighting ↓
Coppell Advisory Solutions LLC 229$11,0080.00%
View complete list of CLOVIS ONCOLOGY INC shareholders